Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    mrx34
Show Display Options
Rank Status Study
1 Recruiting A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
Conditions: Primary Liver Cancer;   Solid Tumors;   Lymphoma;   AML;   ALL;   CLL;   CML in Accelerated or Blast Phase;   Multiple Myeloma;   MDS
Intervention: Drug: MRX34

Indicates status has not been verified in more than two years